{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:29:36Z","timestamp":1787880576419,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gastric cancer (GC) is a significant global public health issue due to its high incidence and limited therapeutic options. This study aimed to explore the role of phospholipase A and acyltransferase 2 (PLAAT2) in GC progression and its molecular mechanisms. A total of 116 pairs of GC and adjacent tissues, along with 116 paraffin-embedded GC tissue sections, were collected from the Cancer Hospital of China Medical University. The expression of PLAAT2 in GC tissues and cells was detected using quantitative reverse transcription\u2013polymerase chain reaction and western blot assays. Its effects on proliferation, migration, invasion, and apoptosis were assessed using functional assays. The impact on mitogen-activated protein kinase (MEK)\/extracellular signal-regulated kinase (ERK) signaling pathway and EMT-related proteins was examined through western blot. Immunoprecipitation\u2013mass spectrometry (IP-MS), co-immunoprecipitation (co-IP), and ubiquitination assays were conducted to elucidate the molecular mechanisms of PLAAT2 to identify PLAAT2-interacting proteins, particularly its role in cMyc posttranslational regulation. In vivo xenograft models further validated the tumor-suppressive role of PLAAT2. We identified PLAAT2 as a differentially expressed gene associated with prognosis in the datasets of patients with GC. PLAAT2 was downregulated in GC and correlated with poor prognosis. Functional experiments demonstrated that PLAAT2 inhibited GC cell proliferation, migration, and invasion through the MEK\/ERK signaling pathway. IP-MS and co-IP revealed that cMyc and tripartite motif containing 32 (TRIM32) were key PLAAT2-binding partners. PLAAT2 facilitated the recruitment of TRIM32 to promote cMyc ubiquitination and degradation, thereby suppressing the MEK\/ERK signaling pathway and reducing oncogenic potential in vitro and in vivo. PLAAT2 functions as a tumor suppressor in GC by recruiting TRIM32 to facilitate cMyc ubiquitination and impair MEK\/ERK-driven oncogenic signaling, highlighting the PLAAT2\/TRIM32\/cMyc axis as a potential therapeutic target.<\/jats:p>","DOI":"10.1038\/s41419-026-08546-y","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:24:34Z","timestamp":1773851074000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["PLAAT2 suppresses gastric cancer progression by facilitating cMyc ubiquitination and inhibiting MEK\/ERK signaling"],"prefix":"10.1038","volume":"17","author":[{"given":"Mingfei","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xialing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhantai","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7067-3708","authenticated-orcid":false,"given":"Yu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"8546_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8546_CR2","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1177\/15353702231181355","volume":"248","author":"J Ampofo-Asiedu","year":"2023","unstructured":"Ampofo-Asiedu J, Tagoe EA, Abrahams DOA, Petershie B, Quaye O. Epstein-Barr virus genotype-1 and Mediterranean + strain in gastric cancer biopsies of Ghanaian patients. Exp Biol Med. 2023;248:1221\u20138.","journal-title":"Exp Biol Med"},{"key":"8546_CR3","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","volume":"33","author":"F Lordick","year":"2022","unstructured":"Lordick F, Carneiro F, Cascinu S, Fleitas T, Haustermans K, Piessen G, et al. Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022;33:1005\u201320.","journal-title":"Ann Oncol"},{"key":"8546_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00726-007-0612-2","volume":"35","author":"RY Shyu","year":"2008","unstructured":"Shyu RY, Hsieh YC, Tsai FM, Wu CC, Jiang SY. Cloning and functional characterization of the HRASLS2 gene. Amino Acids. 2008;35:129\u201337.","journal-title":"Amino Acids"},{"key":"8546_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.cellsig.2006.11.005","volume":"19","author":"FM Tsai","year":"2007","unstructured":"Tsai FM, Shyu RY, Jiang SY. RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cell Signal. 2007;19:989\u201399.","journal-title":"Cell Signal"},{"key":"8546_CR6","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.febslet.2015.04.002","volume":"589","author":"H Wei","year":"2015","unstructured":"Wei H, Wang L, Ren X, Yu W, Lin J, Jin C, et al. Structural and functional characterization of tumor suppressors TIG3 and H-REV107. FEBS Lett. 2015;589:1179\u201386.","journal-title":"FEBS Lett"},{"key":"8546_CR7","doi-asserted-by":"publisher","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","volume":"79","author":"R Dalla-Favera","year":"1982","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA. 1982;79:7824\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8546_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1101\/sqb.2016.81.031153","volume":"81","author":"CV Dang","year":"2016","unstructured":"Dang CV. A Time for MYC: Metabolism and Therapy. Cold Spring Harb Symp Quant Biol. 2016;81:79\u201383.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"8546_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1324045","volume":"15","author":"S Venkatraman","year":"2024","unstructured":"Venkatraman S, Balasubramanian B, Thuwajit C, Meller J, Tohtong R, Chutipongtanate S. Targeting MYC at the intersection between cancer metabolism and oncoimmunology. Front Immunol. 2024;15:1324045.","journal-title":"Front Immunol"},{"key":"8546_CR10","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1128\/MCB.20.7.2423-2435.2000","volume":"20","author":"MA Gregory","year":"2000","unstructured":"Gregory MA, Hann SR. c-Myc proteolysis by the ubiquitin-proteasome pathway: stabilization of c-Myc in Burkitt\u2019s lymphoma cells. Mol Cell Biol. 2000;20:2423\u201335.","journal-title":"Mol Cell Biol"},{"key":"8546_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3727\/096504012X13522227232237","volume":"20","author":"G Han","year":"2012","unstructured":"Han G, Wang Y, Bi W. C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway. Oncol Res. 2012;20:149\u201356.","journal-title":"Oncol Res"},{"key":"8546_CR12","first-page":"11120","volume":"24","author":"ML Zhang","year":"2020","unstructured":"Zhang ML, Zhao TT, Du WW, Yang ZF, Peng W, Cui ZJ. C-MYC-induced upregulation of LINC01503 promotes progression of non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2020;24:11120\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"8546_CR13","doi-asserted-by":"crossref","unstructured":"Yue J, L\u00f3pez JM. Understanding MAPK Signaling Pathways in Apoptosis. Int J Mol Sci. 2020;21:2346.","DOI":"10.3390\/ijms21072346"},{"key":"8546_CR14","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrm1838","volume":"7","author":"BN Kholodenko","year":"2006","unstructured":"Kholodenko BN. Cell-signalling dynamics in time and space. Nat Rev Mol Cell Biol. 2006;7:165\u201376.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8546_CR15","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"8546_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrm1105","volume":"4","author":"JF Hancock","year":"2003","unstructured":"Hancock JF. Ras proteins: different signals from different locations. Nat Rev Mol Cell Biol. 2003;4:373\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"8546_CR17","doi-asserted-by":"crossref","unstructured":"Liang Y, Zhang C, Dai D-Q. Identification of DNA methylation-regulated differentially-expressed genes and related pathways using Illumina 450K BeadChip and bioinformatic analysis in gastric cancer. Pathol Res Pract. 2019;215:152570.","DOI":"10.1016\/j.prp.2019.152570"},{"key":"8546_CR18","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10120-019-01002-1","volume":"23","author":"Y Liang","year":"2020","unstructured":"Liang Y, Zhang CD, Zhang C, Dai DQ. DLX6-AS1\/miR-204-5p\/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer. Gastric Cancer. 2020;23:212\u201327.","journal-title":"Gastric Cancer"},{"key":"8546_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01451-2","volume":"20","author":"B Chen","year":"2021","unstructured":"Chen B, Chan WN, Mui CW, Liu X, Zhang J, Wang Y, et al. STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker. Mol Cancer. 2021;20:147.","journal-title":"Mol Cancer"},{"key":"8546_CR20","doi-asserted-by":"publisher","first-page":"17520","DOI":"10.1074\/jbc.M114.635433","volume":"290","author":"T Uyama","year":"2015","unstructured":"Uyama T, Kawai K, Kono N, Watanabe M, Tsuboi K, Inoue T, et al. Interaction of Phospholipase A\/Acyltransferase-3 with Pex19p: A POSSIBLE INVOLVEMENT IN THE DOWN-REGULATION OF PEROXISOMES. J Biol Chem. 2015;290:17520\u201334.","journal-title":"J Biol Chem"},{"key":"8546_CR21","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1242\/jcs.00679","volume":"116","author":"M St\u00e4hle","year":"2003","unstructured":"St\u00e4hle M, Veit C, Bachfischer U, Schierling K, Skripczynski B, Hall A, et al. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK. J Cell Sci. 2003;116:3835\u201346.","journal-title":"J Cell Sci"},{"key":"8546_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-31","volume":"11","author":"H Cai","year":"2013","unstructured":"Cai H, Xu Y. The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells. Cell Commun Signal. 2013;11:31.","journal-title":"Cell Commun Signal"},{"key":"8546_CR23","doi-asserted-by":"publisher","first-page":"18021","DOI":"10.18632\/oncotarget.7694","volume":"7","author":"L Li","year":"2016","unstructured":"Li L, Liang S, Wasylishen AR, Zhang Y, Yang X, Zhou B, et al. PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway. Oncotarget. 2016;7:18021\u201335.","journal-title":"Oncotarget"},{"key":"8546_CR24","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1194\/jlr.M016873","volume":"52","author":"SA Arisz","year":"2011","unstructured":"Arisz SA, Munnik T. The salt stress-induced LPA response in Chlamydomonas is produced via PLA\u2082 hydrolysis of DGK-generated phosphatidic acid. J Lipid Res. 2011;52:2012\u201320.","journal-title":"J Lipid Res"},{"key":"8546_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12929-015-0210-7","volume":"22","author":"EB Mardian","year":"2015","unstructured":"Mardian EB, Bradley RM, Duncan RE. The HRASLS (PLA\/AT) subfamily of enzymes. J Biomed Sci. 2015;22:99.","journal-title":"J Biomed Sci"},{"key":"8546_CR26","doi-asserted-by":"crossref","unstructured":"Doran BR, Moffitt LR, Wilson AL, Stephens AN, Bilandzic M. Leader Cells: invade and evade-the frontline of cancer progression. Int J Mol Sci. 2024;25:10554.","DOI":"10.3390\/ijms251910554"},{"key":"8546_CR27","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13045-022-01347-8","volume":"15","author":"Y Huang","year":"2022","unstructured":"Huang Y, Hong W, Wei X. The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis. J Hematol Oncol. 2022;15:129.","journal-title":"J Hematol Oncol"},{"key":"8546_CR28","doi-asserted-by":"publisher","first-page":"5931","DOI":"10.1073\/pnas.1918167117","volume":"117","author":"TY Na","year":"2020","unstructured":"Na TY, Schecterson L, Mendonsa AM, Gumbiner BM. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Proc Natl Acad Sci USA. 2020;117:5931\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8546_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/cac2.12138","volume":"41","author":"G Pan","year":"2021","unstructured":"Pan G, Liu Y, Shang L, Zhou F, Yang S. EMT-associated microRNAs and their roles in cancer stemness and drug resistance. Cancer Commun. 2021;41:199\u2013217.","journal-title":"Cancer Commun"},{"key":"8546_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110909","volume":"133","author":"G Babaei","year":"2021","unstructured":"Babaei G, Aziz SG, Jaghi NZZ. EMT, cancer stem cells and autophagy; The three main axes of metastasis. Biomed Pharmacother. 2021;133:110909.","journal-title":"Biomed Pharmacother"},{"key":"8546_CR31","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.7150\/thno.69605","volume":"12","author":"P Peng","year":"2022","unstructured":"Peng P, Zhu H, Liu D, Chen Z, Zhang X, Guo Z, et al. TGFBI secreted by tumor-associated macrophages promotes glioblastoma stem cell-driven tumor growth via integrin \u03b1v\u03b25-Src-Stat3 signaling. Theranostics. 2022;12:4221\u201336.","journal-title":"Theranostics"},{"key":"8546_CR32","doi-asserted-by":"publisher","first-page":"14221","DOI":"10.18632\/oncotarget.13991","volume":"8","author":"JA McCubrey","year":"2017","unstructured":"McCubrey JA, Fitzgerald TL, Yang LV, Lertpiriyapong K, Steelman LS, Abrams SL, et al. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. Oncotarget. 2017;8:14221\u201350.","journal-title":"Oncotarget"},{"key":"8546_CR33","doi-asserted-by":"crossref","unstructured":"Chiu HC, Li CJ, Yiang GT, Tsai AP, Wu MY. Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis. J Clin Med. 2019;8:439.","DOI":"10.3390\/jcm8040439"},{"key":"8546_CR34","doi-asserted-by":"publisher","first-page":"71400","DOI":"10.18632\/oncotarget.12147","volume":"7","author":"B Chen","year":"2016","unstructured":"Chen B, Zeng X, He Y, Wang X, Liang Z, Liu J, et al. STC2 promotes the epithelial-mesenchymal transition of colorectal cancer cells through AKT-ERK signaling pathways. Oncotarget. 2016;7:71400\u201316.","journal-title":"Oncotarget"},{"key":"8546_CR35","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5287971","volume":"2018","author":"Q He","year":"2018","unstructured":"He Q, Li H, Meng F, Sun X, Feng X, Chen J, et al. Methionine Sulfoxide Reductase B1 Regulates Hepatocellular Carcinoma Cell Proliferation and Invasion via the Mitogen-Activated Protein Kinase Pathway and Epithelial-Mesenchymal Transition. Oxid Med Cell Longev. 2018;2018:5287971.","journal-title":"Oxid Med Cell Longev"},{"key":"8546_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2022.109497","volume":"734","author":"J Zhang","year":"2023","unstructured":"Zhang J, Wang Z, Liang Z, Jin C, Shi Y, Fan M, et al. NFIC1 inhibits the migration and invasion of MDA-MB-231 cells through S100A2-mediated inactivation of MEK\/ERK pathway. Arch Biochem Biophys. 2023;734:109497.","journal-title":"Arch Biochem Biophys"},{"key":"8546_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4251\/wjgo.v14.i1.90","volume":"14","author":"SY Tang","year":"2022","unstructured":"Tang SY, Zhou PJ, Meng Y, Zeng FR, Deng GT. Gastric cancer: An epigenetic view. World J Gastrointest Oncol. 2022;14:90\u2013109.","journal-title":"World J Gastrointest Oncol"},{"key":"8546_CR38","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","volume":"28","author":"PE Cockram","year":"2021","unstructured":"Cockram PE, Kist M, Prakash S, Chen SH, Wertz IE, Vucic D. Ubiquitination in the regulation of inflammatory cell death and cancer. Cell Death Differ. 2021;28:591\u2013605.","journal-title":"Cell Death Differ"},{"key":"8546_CR39","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim R, Mermel CH, Porter D, Wei G, Raychaudhuri S, Donovan J, et al. The landscape of somatic copy-number alteration across human cancers. Nature. 2010;463:899\u2013905.","journal-title":"Nature"},{"key":"8546_CR40","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ng.403","volume":"41","author":"MM Pomerantz","year":"2009","unstructured":"Pomerantz MM, Ahmadiyeh N, Jia L, Herman P, Verzi MP, Doddapaneni H, et al. The 8q24 cancer risk variant rs6983267 shows long-range interaction with MYC in colorectal cancer. Nat Genet. 2009;41:882\u20134.","journal-title":"Nat Genet"},{"key":"8546_CR41","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/MCB.01384-09","volume":"30","author":"JB Wright","year":"2010","unstructured":"Wright JB, Brown SJ, Cole MD. Upregulation of c-MYC in cis through a large chromatin loop linked to a cancer risk-associated single-nucleotide polymorphism in colorectal cancer cells. Mol Cell Biol. 2010;30:1411\u201320.","journal-title":"Mol Cell Biol"},{"key":"8546_CR42","doi-asserted-by":"crossref","unstructured":"Zhang X, Peng P, Bao LW, Zhang AQ, Yu B, Li T, et al. Ubiquitin-Specific Protease 1 Promotes Bladder Cancer Progression by Stabilizing c-MYC. Cells. 2024;13:1798.","DOI":"10.3390\/cells13211798"},{"key":"8546_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00512-y","volume":"19","author":"W Zhai","year":"2024","unstructured":"Zhai W, Yang W, Ge J, Xiao X, Wu K, She K, et al. ADAMTS4 exacerbates lung cancer progression via regulating c-Myc protein stability and activating MAPK signaling pathway. Biol Direct. 2024;19:94.","journal-title":"Biol Direct"},{"key":"8546_CR44","doi-asserted-by":"publisher","first-page":"13511","DOI":"10.1002\/cam4.6020","volume":"12","author":"M Lin","year":"2023","unstructured":"Lin M, Fang Z, Lin X, Zhou W, Wang Y, Han S, et al. TRIM55 inhibits colorectal cancer development via enhancing protein degradation of c-Myc. Cancer Med. 2023;12:13511\u201321.","journal-title":"Cancer Med"},{"key":"8546_CR45","volume":"830","author":"D Zhang","year":"2025","unstructured":"Zhang D, Zhang X, Chang S, Zhao Y, Zhang L. E2F1 activates USP19 to affect the stability of c-Myc to facilitate the progression of hepatocellular carcinoma. Mutat Res. 2025;830:111902.","journal-title":"Mutat Res"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08546-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08546-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08546-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:20:39Z","timestamp":1774984839000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08546-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8546"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08546-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"25 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants involved in this study have signed informed consent forms, and the research protocol was approved by the Ethics Committee of the Cancer Hospital of China Medical University. Additionally, the animal experimental protocol for this study has been formally approved by the Laboratory Animal Welfare and Ethics Committee of China Medical University. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"314"}}